Skip to main content
Livermore
Livermore
ZHEN

Archetype Wealth Partners

SEC CIK
0001769089
Latest filing
Aug 14, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Archetype Wealth Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of BSX by Archetype Wealth Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,962−100.0%Sold outHolders
Q1 20263,962$249.0K<0.1%00.0%UnchangedHolders
Q4 20253,962$378.0K<0.1%−5,402−57.7%ReducedHolders
Q3 20259,364$914.0K0.1%+3,341+55.5%AddedHolders
Q2 20256,023$647.0K0.1%00.0%UnchangedHolders
Q1 20256,023$608.0K0.1%00.0%UnchangedHolders
Q4 20246,023$538.0K0.1%−351−5.5%ReducedHolders
Q3 20246,374$534.0K0.1%+30+0.5%AddedHolders
Q2 20246,344$489.0K0.1%00.0%UnchangedHolders
Q1 20246,344$435.0K0.1%00.0%UnchangedHolders
Q4 20236,344$367.0K0.1%−454−6.7%ReducedHolders
Q3 20236,798$359.0K0.1%00.0%UnchangedHolders
Q2 20236,798$368.0K0.1%−500−6.9%ReducedHolders
Q1 20237,298$365.0K0.1%00.0%UnchangedHolders
Q4 20227,298$338.0K0.1%−1,000−12.1%ReducedHolders
Q3 20228,298$321.0K0.1%−4,180−33.5%ReducedHolders
Q2 202212,478$465.0K0.1%+1,625+15.0%AddedHolders
Q1 202210,853$481.0K0.1%00.0%UnchangedHolders
Q4 202110,853$461.0K0.1%−500−4.4%ReducedHolders
Q3 202111,353$493.0K0.2%00.0%UnchangedHolders
Q2 202111,353$485.0K0.2%00.0%UnchangedHolders
Q1 202111,353$439.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.